TMPRSS2 is a tumor suppressor and its downregulation promotes antitumor immunity and immunotherapy response in lung adenocarcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
TMPRSS2 is a tumor suppressor and its downregulation promotes antitumor immunity and immunotherapy response in lung adenocarcinoma ; volume:25 ; number:1 ; day:11 ; month:6 ; year:2024 ; pages:1-17 ; date:12.2024
Respiratory research ; 25, Heft 1 (11.6.2024), 1-17, 12.2024
- Urheber
-
Liu, Zhixian
Lu, Qiqi
Zhang, Zhilan
Feng, Qiushi
Wang, Xiaosheng
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12931-024-02870-7
- URN
-
urn:nbn:de:101:1-2408190943062.720791783266
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Liu, Zhixian
- Lu, Qiqi
- Zhang, Zhilan
- Feng, Qiushi
- Wang, Xiaosheng
- SpringerLink (Online service)
Ähnliche Objekte (12)
Regnase-1 downregulation promotes pancreatic cancer through myeloid-derived suppressor cell-mediated evasion of anticancer immunity
TH9 cells in anti-tumor immunity
TMPRSS2 isoform 1 downregulation by G-quadruplex stabilization induces SARS-CoV-2 replication arrest
Induction of antitumor immunity through xenoplacental immunization
Cytokine-induced killer cells promote antitumor immunity
Necroptosis stimulates interferon-mediated protective anti-tumor immunity
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Integrin CD11b activation drives anti-tumor innate immunity
Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity
Modulation of antitumor immunity by isocitrate dehydrogenase-mutated tumors
Targeting tumor cells with antibodies enhances anti-tumor immunity
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Regnase-1 downregulation promotes pancreatic cancer through myeloid-derived suppressor cell-mediated evasion of anticancer immunity
TH9 cells in anti-tumor immunity
TMPRSS2 isoform 1 downregulation by G-quadruplex stabilization induces SARS-CoV-2 replication arrest
Induction of antitumor immunity through xenoplacental immunization
Cytokine-induced killer cells promote antitumor immunity
Necroptosis stimulates interferon-mediated protective anti-tumor immunity
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Integrin CD11b activation drives anti-tumor innate immunity
Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity
Modulation of antitumor immunity by isocitrate dehydrogenase-mutated tumors
Targeting tumor cells with antibodies enhances anti-tumor immunity
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Regnase-1 downregulation promotes pancreatic cancer through myeloid-derived suppressor cell-mediated evasion of anticancer immunity
TH9 cells in anti-tumor immunity
TMPRSS2 isoform 1 downregulation by G-quadruplex stabilization induces SARS-CoV-2 replication arrest
Induction of antitumor immunity through xenoplacental immunization
Cytokine-induced killer cells promote antitumor immunity
Necroptosis stimulates interferon-mediated protective anti-tumor immunity
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Integrin CD11b activation drives anti-tumor innate immunity
Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity
Modulation of antitumor immunity by isocitrate dehydrogenase-mutated tumors
Targeting tumor cells with antibodies enhances anti-tumor immunity